Contact us.
There was no tutorial as only one person attended.
We will used these materials in the next tutorial on Monday 26th. January as there is quite a lot to discuss.
There will be no tutorial - Valerie and I are attending a dinner for an old colleague who is leaving Stepping Hill hospital.
19 January 2015.
37.
|
Green-top
guideline development
|
38.
|
Non-invasive
prenatal testing NIPT
|
39.
|
Risk
management. Reporting problems
|
40.
|
Education
|
41.
|
Viva.
PMB.
|
1. Green-top guideline
development.
This question relates
to the Green-top and other RCOG guidelines and how evidence is evaluated and
given importance and the strength of recommendations is graded.
This is the sort of
esoteric stuff that could be included in an EMQ or SAQ.
Question 1.
Lead-in
Which of the
following statements, if any, are true.
- CNST
requires consultants to follow the advice in GTGs
- CNST
requires consultants to follow the advice in GTGs, unless the consultant
has phoned the CNST to obtain permission for alternative management
- Consultants
deviating from the advice in a GTG should send details to the hospital
lawyer
- Consultants
are responsible for the decisions they make about patient care and can
choose to deviate from the advice in GTGs.
- A
consultant choosing different care for a patient to that in a guideline
should fully document the decision at the time it is made.
Pick the option from
the list below that best fits.
Option List
|
i
|
|
ii
|
|
iii
|
|
iii + iv
|
|
iv + v
|
Question 2.
Lead-in
Grade A
recommendations have specific requirements. Choose the option from the list
below that best fits.
Option List
|
a positive Cochrane
review is a requirement for a Grade A recommendation
|
|
a Grade A recommendation can be based on
high-quality systematic reviews of case series
|
|
a Grade A recommendation can be based on a single
systematic review or RCT.
|
|
a Grade A recommendation must include a
meta-analysis or systematic review of RCTs
|
|
a Grade A recommendation can be an extrapolation
from studies graded 2++ or better.
|
Question 3.
Lead-in
Which, if any, of the
following statements are true about Grade A recommendations.
- ≥
1 meta analysis or systematic review can be sufficient for a Grade A
recommendation
- ≥
1 RCT rated 1++ and applicable to the target population can be sufficient
for a Grade A recommendation
- a
systematic review of RCTs can be sufficient for a Grade A recommendation
- studies
rated as 1+ which are applicable to the target population and with
consistent results can be
sufficient for a Grade A recommendation
Option List
|
i
|
|
i + ii
|
|
i + iii
|
|
all of the above
|
|
none of the above
|
Question 4.
Lead-in
What other grades are
there?
Question 5.
Lead-in
What criteria are
associated with these other grades?
2. Non-invasive prenatal testing.
Abbreviations.
CAH: congenital
adrenal hyperplasia
DSD: disorder
of sexual development
NIPD: non-invasive
prenatal diagnosis
NIPT: non-invasive
prenatal testing
RAADP: routine
antenatal anti-D prophylaxis.
SIP15: RCOG’s
Scientific Impact Paper No. 15:
“Non-invasive Prenatal Testing for Chromosomal Abnormality using Maternal
Plasma DNA”. March 2014.
UKGTN: UK Genetic Testing Network
Question 1.
Lead-in
What is
the definition of NIPT?
Option List
A.
|
any test
to detect fetal anomaly, disease or significant problem that does not involve
invasive testing of the mother
|
B.
|
any test to detect fetal anomaly, disease or
significant problem that does not involve invasive testing of the mother,
excluding TVS
|
C.
|
any test for fetal chromosomal anomaly that does not
involve invasive testing of the mother
|
D.
|
any test for fetal chromosome or genetic anomaly that
does not involve invasive testing of the mother.
|
E.
|
none of the above
|
Question 2.
Lead-in
What is
the potential of NIPT using cffDNA and RNA?
Option List
A.
|
description
of the full fetal genome
|
B.
|
description of the full fetal genome with the exception
of disorders arising from mitochondrial DNA
|
C.
|
description of the full fetal genome with the exception
of disorders arising from mitochondrial RNA
|
D.
|
description of the full fetal genome and most
structural anomalies
|
E.
|
none of the above
|
Question 3.
Lead-in
Which of
the following statements is true?
Option List
1.
|
cffDNA
is found in maternal serum in greater quantities than maternal cell-free DNA
|
2.
|
cffDNA is found in maternal serum in lesser quantities than maternal cell-free
DNA
|
3.
|
the quantity of cffDNA rises throughout pregnancy,
peaking at placental separation
|
4.
|
cffDNA diminishes after placental delivery but remains
detectable for at least 6 weeks
|
5.
|
cffDNA diminishes after placental delivery but remains
detectable for at least 1 year
|
Question 4.
Lead-in
Which, if
any, of the following statements are true?
Statements.
1.
cffDNA
is usually detectable from 4-5 weeks’ gestation
2.
cffDNA is not usually detectable at gestations
< 12 weeks
3.
the quantity of cffDNA rises throughout
pregnancy, peaking at placental separation
4.
cffDNA diminishes after placental delivery but
remains detectable for at least 6 weeks
5.
cffDNA diminishes after placental delivery but
remains detectable for at least 1 year
Option List
A.
|
1
|
B.
|
2
|
C.
|
3
|
D.
|
4
|
E.
|
5
|
F.
|
1 + 3
|
G.
|
1 + 4
|
H.
|
1 + 5
|
I.
|
2 + 3
|
J.
|
2 + 4
|
K.
|
2 + 5
|
Question 5.
Lead-in
Which, if
any, of the following statements is true about cffDNA in maternal blood?
Statements.
1. cffDNA originates in the placenta, not
the fetus
2. cffDNA
originates in fetal squames
3. cffDNA
originates in fetal blood cells
4. cffDNA
occurs in maternal blood due to trans-membrane osmosis
5. cffDNA
occurs in maternal blood due to feto-maternal transfusion
Option List
A.
|
1
|
B.
|
2
|
C.
|
3
|
D.
|
4
|
E.
|
5
|
F.
|
1 + 4
|
G.
|
2 + 4
|
H.
|
2 + 5
|
I.
|
3 + 5
|
Question 6.
Lead-in
Which. if
any, of the following statements are true?
Statements.
1.
tests
using cffDNA are based on detecting paternally-derived fetal DNA in maternal
blood.
2.
tests
using cffDNA are based on detecting maternally-derived fetal DNA in maternal
blood.
3.
tests
using cffDNA are based on detecting DNA from the fetal Y chromosome.
4.
tests
using cffDNA may involve shotgun sequencing.
5.
tests
using cffDNA may involve shotgun nuptials.
Option List
A.
|
1
|
B.
|
2
|
C.
|
3
|
D.
|
4
|
E.
|
5
|
F.
|
1 + 4
|
G.
|
1 + 5
|
H.
|
2 + 4
|
I.
|
2 + 5
|
J.
|
3 + 4
|
K.
|
3 + 5
|
Question 7.
Lead-in
Which. if
any, of the following statements are true?
Option List
A.
|
detection
of the SRY sequence in cffDNA means that the fetus is female
|
B.
|
detection of the SRY sequence in cffDNA means that the
fetus is male
|
C.
|
detection of the SRY sequence in cffDNA means that the
fetus is male unless it has a DSD
|
D.
|
detection of the SRY sequence in cffDNA means that the
fetus has Klinefelter’s syndrome
|
E.
|
detection of the SRY sequence in cffDNA means that the
fetus has 45X0/46XY mosaicism.
|
Question 8.
Lead-in
Which. if
any, of the following statements are true?
Option List
There is
none.
A.
|
Rhesus D
status can be determined accurately from 12 weeks’ gestation using cffDNA
|
B.
|
Rhesus D pseudogene is more common in Africans than
Caucasians
|
C.
|
People with the RhD pseudogene are at risk of
isoimmumisation.
|
D.
|
People with the RhDu blood type may be identified as
Rh-ve or Rh+ve on routing testing
|
E.
|
People with the RhDu blood type are particularly prone
to isoimmunisation
|
Question 9.
Lead-in
Which. if
any, of the following statements are true in relation to cffDNA in maternal
blood?
Option List
A.
|
Checking
the fetal RhD status is best left until > 16 weeks’ gestation
|
B.
|
Checking the fetal Kell status is not yet routinely
available
|
C.
|
Checking the fetal Kell status is best left until >
20 week’s gestation
|
D.
|
Routine screening of Rh –ve women for fetal RhD status
reduces the use of RAADP by up to 10%
|
E.
|
Routine screening of Rh –ve women for fetal RhD status
reduces the use of RAADP by up to 40%
|
Question 10
Lead-in
List the
other situations in which cffDNA in maternal serum can be used for clinical
benefit.
Other questions.
1.
cffDNA levels in maternal blood are raised in pregnancies affected by Down’s
syndrome.
True / False
2. screening
for Down’s syndrome using cffDNA has both sensitivity and specificity close to
100%
True / False
3. What
is the value of cffDNA in women at risk of having a baby with CAH?
4. How
might cffDNA be used to screen for conditions such as cystic fibrosis?
5. What
is the role of amniocentesis if a cffDNA screen for a condition such as cystic
fibrosis proved +ve?
6. cffDNA screening
for achondroplasia and thanatophoric dysplasia is now available on the NHS for
women at risk of an affected baby. True
/ False
7. What
is meant by “contingent” screening using cffDNA in relation to Down’s syndrome?
8. What
is an “allele”?
9. What
is a “wild-type” allele?
10. What
is the alternative to a “wild-type” allele?
3. Risk Management/ disciplinary procedures.
Lead-in.
The following scenarios relate to risk management /
disciplinary procedures.
Pick one option from the option list.
Each option can be used once, more than once or not at
all.
Abbreviations.
DOH: Department
of Health.
Option list.
A.
allow the practice to
continue
B.
stop the practice
until a full investigation has been done
C.
stop the practice
permanently
D.
arrange an
investigation by a senior consultant from another hospital
E.
decide the practice
does not involve added risk
F.
declare the risk to be
acceptable
G.
cancel admissions for
surgery
H.
arrange adverse
incident analysis
I.
arrange audit
J.
arrange research
K.
arrange a formal
warning for the doctor
L.
arrange retirement for
the doctor
M.
arrange dismissal for
the doctor
N.
consult the on-call
consultant
O.
consult the Clinical
Director
P.
consult the
Educational Supervisor / College Tutor
Q.
consult the Medical
Director
R.
consult the Chief
Executive
S.
consult the
Postgraduate Dean.
T.
consult the hospital’s
lawyer
U.
write to Her Majesty
at Buckingham Palace
V.
consult your Medical
Defence Body
W.
consult the British
Medical Association
X.
consult the RCOG
Y.
report the matter to
the GMC
Z.
allow return to work
AA.
allow return to work,
but offer support
BB.
arrange a “return to
work” package specific to the doctor
CC.
none of the above
Scenario 1
You are the Clinical Director.
1 62-year-old Consultant colleague has been off work for 8 weeks with a broken
arm sustained in a skiing accident. He sends you a certificate from his
specialist to say that he is now fit to return to work. He indicates that he
wishes to return to work immediately. What action will you take?
Scenario 2
You are the Clinical Director.
1 62-year-old Consultant colleague has been off work for 8 weeks with a severe
bereavement reaction to the suicide of a family member. He sends you a
certificate from his GP to say that he is now fit to return to work. He
indicates that he wishes to return to work immediately. What action will you
take?
Scenario 3
You are the Clinical Director.
1 62-year-old Consultant colleague has been off work for 6 months after having
a coronary thrombosis. He sends you a certificate from his specialist to say
that he is now fit to return to work. He indicates that he wishes to return to
work immediately. What action will you take?
Scenario 4
You are the Clinical Director.
A 62-year-old Consultant has returned to work after four months’ sick leave
after a coronary thrombosis. He has three cases on his first operating list and
all have complications reported by the Sister on the gynaecology ward. What
action will you take?
Scenario 5.
A Consultant has been in her
first consultant post for two months. Three of the four patients on a single
operating list develop post-operative wound infections. What action will you
take?
Scenario 6.
You have recently been
appointed Clinical Director. A consultant has been in post for ten years and
prefers to operate with the same nurse assistant. No complications have been
reported. What action will you take?
Scenario 7.
You are the Clinical Director. A consultant has an operating list in a peripheral unit 20 miles from the
main hospital. There is no resident doctor with post-operative care being
provided by nurses. The cases dealt with on the list traditionally were minor,
day-cases. You have been told that the
consultant, who was appointed 6 months ago, has recently been doing
hysterectomies and prolapse repairs to get the waiting list down. What action will you take?
Scenario 8.
You are the Clinical Director.
The blood bank informs you that there is a problem with supplies and fully
cross-matched blood cannot be guaranteed for tomorrow’s arranged surgical
cases.
What action will you take?
Scenario 9.
You are the on-call SpR. It is
8 pm. The blood bank informs you that there is a problem with supplies and
fully cross-matched blood cannot be guaranteed for tomorrow’s arranged surgical
cases.
What action will you take?
Scenario 10.
An SpR is half an hour late for
starting his duties on three occasions in one week. His consultant wishes to
have this dealt with as a disciplinary matter to “nip it in the bud” and teach
him a lesson. He reports it to you, the Clinical Director asking you to
discipline the doctor. What action will you take?
Scenario 11
An SpR gets into an argument
with the senior midwife on the labour ward and in the heat of the moment slaps
her across the face. You are the Clinical Director and the matter is reported
to you next day.
Scenario 12
Your consultant is the Clinical
Director and a nasty man. You apply 6 months in advance for study leave for the
week before the written part of the Part Ii MRCOG exam. He tells you that he plans
to go on holiday at that time and you are not going to get any leave. In
addition, he tells you that if you complain about this he will give you a
terrible reference and tell all his consultant friends that you are a waste of
space in order to ruin your career. What action can you take?
Scenario 13
A SpR fails an OSATS, but
falsifies his records to indicate that it has been completed satisfactorily.
You are the Educational Advisor and this is brought to your attention. What
action will you take ?>
Scenario 14
A SpR2 uploaded reflective
practice putting him in a good light after a case which had been handled
sub-optimally by him.
Scenario 15
You are an FY2 and assist
the senior consultant at a hysterectomy. The operation goes well initially, but
then there is a lot of bleeding and a ureter is cut. The consultant urologist
attends and repairs the ureter. The woman bleeds vaginally that evening and is
taken back to theatre by another consultant and ends up in the ICU. You became
convinced during the operation that you could smell alcohol on the consultant
gynaecologist’s breath. What are your responsibilities?
Scenario 16
When do you need to inform the Consultant on-call?
Scenario 17
When do you need to inform the Clinical Director?
Scenario 18
When do you need to inform the Medical Director?
Scenario 19
When do you need to inform the GMC?
Scenario 20
What are the roles of the BMA and MDU?
Scenario 21
What are the differences between verbal and written
warnings?
4. Education.
Lead-in.
The following scenarios relate to medical education
Pick one option from the option list.
Each option can be used once, more than once or not at
all.
Abbreviations.
EMQ: extended, matching question.
PBL: problem-based learning.
Scenario 1.
A woman is admitted with an
eclamptic seizure. The acute episode is dealt with and she is put on an appropriate
protocol. You wish to use the case to outline key aspects of PET and eclampsia
to the two medical students who are on the labour ward with you. Which would be
the most appropriate approach?
Scenario 2.
You have been asked to provide
a summary of the key aspects of the recent Maternal Mortality Meeting to the
annual GP refresher course. There are likely to be 100 attendees. Which would
be the most appropriate approach?
Scenario 3.
You have been asked to teach a
new trainee the use of the ventouse. Which would be the most appropriate
approach?
Scenario 4.
You have been asked to teach a group of medical students
about PPH. To your surprise you find that they have good basic knowledge. Which
technique will you apply to get the most from the teaching session?
Scenario 5.
Your consultant has asked you to get the unit’s medical
students to prepare some questions about breech delivery which they can ask of
their peers when they next meet. Which technique will you use?
Scenario 6.
You have been asked to discuss
2ry. amenorrhoea with your unit’s medical students. You are uncertain about the
amount of basic physiology and endocrinology they remember from basic science
teaching. Which technique will you use?
Scenario 7
The RCOG has asked you to chair
a Green-top Guideline development committee. You find that there is very little
by way of research evidence to help with the process. The College has assembled
a team of consultants with expertise and interest in the subject. Which
technique would be best to reach consensus on the various elements of the GTG?
Scenario 8
Which of the listed teaching
techniques is least likely to lead to deep learning?
Scenario 9
An interactive lecture with
EMQs is the best method of teaching. True or false.
Scenario 10
Only 20% of what is taught in a lecture is retained. True
or false.
Scenario 11.
The main role of the teacher is information provision. True
or false.
Scenario 12.
The main role of the teacher is to be a role model. True or false.
Option list.
- brainstorming.
- brainwashing
- cream cake circle.
- Delphi technique.
- demonstration &
practice using clinical model.
- doughnut round.
- interactive lecture with
EMQs.
- lecture.
- 1 minute preceptor
method.
- teaching peers / junior
colleagues
- schema activation.
- schema refinement.
- small group discussion.
- snowballing.
- snowboarding.
- true
- false